Hostname: page-component-848d4c4894-cjp7w Total loading time: 0 Render date: 2024-06-22T09:50:56.415Z Has data issue: false hasContentIssue false

P0209 - Neurocognitive functions as endophenotypes in schizophrenia and bipolar disorder

Published online by Cambridge University Press:  16 April 2020

G.M. Sachs
Affiliation:
Medical University of Vienna, Department of Psychiatry and Psychotherapy, Vienna, Austria
O. Pintsov
Affiliation:
Medical University of Vienna, Department of Psychiatry and Psychotherapy, Vienna, Austria
B. Winklbaur
Affiliation:
Medical University of Vienna, Department of Psychiatry and Psychotherapy, Vienna, Austria
A. Erfurth
Affiliation:
Medical University of Vienna, Department of Psychiatry and Psychotherapy, Vienna, Austria
G. Lenz
Affiliation:
Medical University of Vienna, Department of Psychiatry and Psychotherapy, Vienna, Austria
K. Thau
Affiliation:
Medical University of Vienna, Department of Psychiatry and Psychotherapy, Vienna, Austria

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Cognitive dysfunctions have been well established in patients with schizophrenia (SZ). Recent studies also showed persistent cognitive impairments in patients with bipolar disorder (BD) in all phases of the disorder including the remission phase. Specific cognitive domains have been considered as candidate endophenotypes in SZ and BD. The aim of this study was to investigate the diagnostic specificity of neurocognitive deficits BD and SZ patients during a stable phase of the illness.

Methods:

40 patients with schizophrenia (20 female, 30.4 ±8,1 years) were compared with 40 bipolar patients (27 female, 34.7±10.4 years) and 43 healthy volunteers (24 female, 34.7 ± 8.7 years). Executive functions (WCST), attention (CPT), immediate and delayed verbal memory (VLMT) and verbal fluency (RWT) were assessed. Differences in neurocognitive functions between diagnostic groups were analysed for each domain by analyses of covariance (ANCOVA analysis with age, education, IQ, gender and medication as covariates).

Results:

SZ and BD patients performed worse than control subjects in the WCST (p<0.001), VLMT (p<0.01) and in the CPT (p<0.03). There was no significant difference in the WCST and VLMT between SZ and BD patients. However, in the CPT, SZ patients showed a significantly greater impairment than BD patients (p<0.001). In BP patients deficits in the CPT were associated with the number of illness episodes.

Conclusions:

The findings are comparable to previous results suggesting that the specific profile of the deficits seems to differ between the diagnosis, while the same underlying domains describe neurocognitive functioning in both groups.

Type
Poster Session I: Schizophrenia and Psychosis
Copyright
Copyright © European Psychiatric Association 2008
Submit a response

Comments

No Comments have been published for this article.